Blepharitis Treatments
Find Blepharitis Treatments
Brand Name
Natacyn
Generic Name
Natamycin
View Brand Information FDA approval date: June 12, 2021
Classification: Polyene Antimicrobial
Form: Suspension
What is Natacyn (Natamycin)?
NATACYN™ 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis. As in other forms of suppurative keratitis, initial and sustained therapy of fungal keratitis should be determined by the clinical diagnosis, laboratory diagnosis by smear and culture of corneal scrapings and drug response. Whenever possible the in vitro activity of natamycin against the responsible fungus should be determined. The effectiveness of natamycin as a single agent in fungal endophthalmitis has not been established.
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Summary: The goal of this clinical trial is to learn if adjunctive topical Cyclosporine A eye drops combined with standard of care topical Natamycin treatment improves vision outcomes in patients with fungal keratitis.